AXSM Earnings

Quarterly EPS
$-1.34
Q3 2024
$-1.54
Q4 2024
$-1.22
Q1 2025
$-0.97
Q2 2025
$-0.94
Q3 2025
$-0.56
Q4 2025
$-1.26
Q1 2026
$-0.99
Q2 2026
Latest Revenue218.4M
Latest Net Income-51314000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.99218.4M-51314000+45.5%-2.1%
Q1 2026-$1.26191.2M-64542000+57.4%-3.3%
Q4 2025-$0.56196.0M-28559000+65.0%+63.6%
Q3 2025-$0.94171.0M-47229000+63.2%+29.9%
Q2 2025-$0.97150.0M-47973000+72.1%+41.9%
Q1 2025-$1.22121.5M-59413000+62.0%+15.3%
Q4 2024-$1.54118.8M-74912000+66.0%+26.0%
Q3 2024-$1.34104.8M-64602000+81.3%-1.5%
Q2 2024-$1.6787.2M-79345000
Q1 2024-$1.4475.0M-68357000
Q4 2023-$2.0871.5M-98651000
Q3 2023-$1.3257.8M-62199000
Axsome Therapeutics (AXSM) — Earnings